
    
      A Single-arm, Open, Multi-center Phase II Clinical Trial of Mitoxantrone HCL Liposome
      Injection in Subjects With Relapsed Diffuse Large B-cell Lymphoma and and Peripheral T/NK
      Lymphomas with dose of 20 mg/m2.
    
  